8-K filing — SRX Global Inc. (SRXH)
Filed: 2026-09-02 AccNo: 0001493152-26-041250 Size: 706 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Stocks · News reference
SRX HealthSolutions Q3 EPS $(0.36) Up From $(44.51) YoY, Sales $3.392M Up From $2.673M YoY
SRX HealthSolutions (AMEX:SRXH) reported quarterly losses of $(0.36) per share. This is a 99.19 percent increase over losses of $(44.51) per share from the same period last year. The company reported $3.392 million in
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
SRX Global Announces Purchase Of Senior Secured Debt In CERo Therapeutics Holdings; Terms Not Disclosed
SRX HealthSolutions Q3 2026 Earnings Call: Complete Transcript
On Thursday, SRX HealthSolutions (AMEX:SRXH) discussed third-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive